TYPE 2 DIABETES
Clinical trials for TYPE 2 DIABETES explained in plain language.
Never miss a new study
Get alerted when new TYPE 2 DIABETES trials appear
Sign up with your email to follow new studies for TYPE 2 DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine targets group b strep in seniors
⭐️ VACCINE ⭐️ CompletedThis early-stage trial tested a new vaccine against Group B Streptococcus (GBS) in 90 healthy adults aged 55 to 75. Participants received three doses of the vaccine or a placebo, and researchers monitored safety and immune response for six months. The goal is to see if the vaccin…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Minervax ApS • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 26, 2026 13:27 UTC
-
New daily pill aims to tame type 2 diabetes safely over the long haul
Disease control CompletedThis study tests the long-term safety of an experimental oral drug called orforglipron in adults with type 2 diabetes whose blood sugar is not well controlled by diet, exercise, or other diabetes pills. Participants take the drug once daily for about a year, and researchers monit…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New pill HRS-7535 takes on diabetes in Head-to-Head trial
Disease control CompletedThis study compares a new drug, HRS-7535, to an existing diabetes medication, dapagliflozin, in adults with type 2 diabetes whose blood sugar is not well controlled with metformin alone. The goal is to see if HRS-7535 works better at lowering blood sugar and body weight over 32 w…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could when you eat help control diabetes? new study tests meal timing vs. calorie counting
Disease control CompletedThis trial investigates whether changing how often and when people with type 2 diabetes eat can improve weight, blood sugar, and cholesterol. Over 12 weeks, participants follow one of three eating plans: a standard 6-meal diet, a 3-meal diet, or time-restricted eating (eating all…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Akdeniz University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Church-Based diabetes program helps families fight high blood sugar
Disease control CompletedThis study tested a family-focused diabetes education program delivered in Marshallese faith-based organizations. Over 300 adults with type 2 diabetes and their family members took part. The goal was to see if group education in a familiar community setting could improve blood su…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Arkansas • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New computer tool aims to improve blood sugar control in hospital diabetes patients
Disease control CompletedThis study tested an electronic glucose management system (eGMS) designed to help doctors decide insulin doses for hospitalized patients with type 2 diabetes. The trial compared the eGMS to the usual insulin ordering protocol in 140 patients. The goal was to see if the eGMS could…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Far Eastern Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Laser acupuncture shows promise for diabetes body shape
Disease control CompletedThis completed trial tested whether laser acupuncture could improve body shape index (ABSI) in 50 women aged 40-50 with uncontrolled type 2 diabetes and obesity. Participants received either real or sham laser acupuncture twice a week for 12 weeks, plus a low-glycemic diet. The s…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Tailored diets may help tame type 2 diabetes
Disease control CompletedThis study tested whether personalized dietary advice helps people with early-stage type 2 diabetes control their blood sugar better than standard advice or usual care. About 255 participants were split into three groups: personalized diet, standardized diet, or usual care. Resea…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Ojibwe-Focused diabetes program aims to help families manage together
Disease control CompletedThis study tested a culturally tailored program called Together Overcoming Diabetes (TOD) for American Indian families in Ojibwe communities. Adult caregivers with type 2 diabetes and their youth (ages 10-16) worked with local health coaches to set health goals. The program inclu…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Johns Hopkins Bloomberg School of Public Health • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a culturally relevant diet cut diabetes risk in african americans?
Disease control CompletedThis study tested whether making U.S. dietary guidelines more culturally relevant for African Americans could improve diet quality and reduce type 2 diabetes risk. 63 overweight or obese African American adults with at least three diabetes risk factors attended weekly classes for…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
App-Based videos aim to boost birth weights in diabetic pregnancies
Disease control CompletedThis study tested whether adding a smartphone app with short videos on mental health, diet, exercise, and insulin adjustment to standard care could improve blood sugar control and birth weight in pregnant women with diabetes. Over 600 women participated. The goal was to see if th…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can two old drugs save heart failure patients?
Disease control CompletedThis study tested two drugs—hydralazine-ISDN and metformin—in 1100 people with chronic heart failure and reduced heart function. Some participants also had diabetes or insulin resistance. The goal was to see if these drugs could lower the risk of death or hospital stays due to wo…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE4 • Sponsor: Henrik Wiggers • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New weekly shot challenges semaglutide for diabetes and weight loss
Disease control CompletedThis Phase 3 study tested a new drug called IBI362 (mazdutide) against the well-known semaglutide in 349 Chinese adults with early type 2 diabetes and obesity. Participants received weekly injections for 32 weeks, with some continuing for an extra 24 weeks. The main goal was to s…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a common diabetes drug protect transplanted kidneys?
Disease control CompletedThis study tested whether dapagliflozin, a drug used for type 2 diabetes, can lower blood pressure in people who have received a kidney transplant. Fifty-two participants took either the drug or a placebo for 12 weeks. The goal was to see if the drug helps control blood pressure …
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
New weekly insulin put to the test during exercise and fasting
Disease control CompletedThis study looked at how safe a new once-weekly insulin (insulin icodec) is during exercise and long periods without food in 30 adults with type 2 diabetes. Participants first took a daily insulin for a week, then switched to the weekly insulin for up to 14 weeks. The goal was to…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New diabetes drug SHR-3167 takes on insulin in Head-to-Head trial
Disease control CompletedThis study tests a new medicine called SHR-3167 against a standard insulin (insulin glargine) for people with type 2 diabetes. About 275 adults who are not on insulin yet, but take metformin (alone or with another diabetes drug), will receive either SHR-3167 or insulin glargine. …
Matched conditions: TYPE 2 DIABETES
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Weekly shot could replace daily insulin for diabetes
Disease control CompletedThis study tested a new once-weekly injection called IcoSema, which combines two diabetes drugs (insulin icodec and semaglutide), against daily insulin glargine in 485 adults with type 2 diabetes whose blood sugar was not well controlled on oral medications. The goal was to see i…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New shot for obesity and diabetes passes first safety test
Disease control CompletedThis early study tested a single injection of a new drug called ENT-03S in 49 people who were either obese but otherwise healthy, or had both obesity and type 2 diabetes. The main goal was to check safety and how the drug moves through the body. Participants were randomly assigne…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Metabolics Pharma • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New smart insulin pump could simplify diabetes management
Disease control CompletedThis completed trial tested a new automated insulin delivery system called twiist in 307 adults with insulin-treated type 2 diabetes. The system combines an insulin pump, a continuous glucose monitor, and a smart algorithm to automatically adjust insulin. The main goal was to see…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Deka Research and Development • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New insulin algorithm aims to tame type 2 diabetes
Disease control CompletedThis study tested a next-generation automated insulin delivery system in 48 adults with type 2 diabetes aged 16–70. The goal was to see if the smart algorithm could keep blood sugar in a safer range, reducing both low and high blood sugar events. Participants used a continuous gl…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Which diet plan best tames type 2 diabetes? new study tests three approaches
Disease control CompletedThis study tested three different diet plans in 108 overweight adults with type 2 diabetes to see which best improves blood sugar control. Participants followed either standard nutrition advice, a structured meal plan with special diabetes drinks, or that same structured plan plu…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Joslin Diabetes Center • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Dairy debate: Full-Fat or Low-Fat for diabetes control?
Disease control CompletedThis study looked at whether eating more dairy products (full-fat or low-fat) helps people with type 2 diabetes manage their blood sugar, weight, and heart health. 112 adults with type 2 diabetes who ate fewer than 3 servings of dairy per day were assigned to add either full-fat …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Joslin Diabetes Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New diabetes drug shows promise for safe ramadan fasting
Disease control CompletedThis study looked at whether starting tirzepatide, a once-weekly injection for type 2 diabetes, before Ramadan helps people manage their blood sugar safely while fasting. 166 adults with uncontrolled diabetes who planned to fast took part. Researchers measured changes in blood su…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
Eat in 10 hours, live better? new study tests Time-Restricted eating
Disease control CompletedThis study looked at whether eating only within a 10-hour window each day helps overweight adults aged 50 to 75 with prediabetes lose fat and improve their metabolism. 57 participants either followed the 10-hour eating plan or their usual 13-hour eating pattern, while tracking th…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
New pill HRS-7535 aims to tame type 2 diabetes
Disease control CompletedThis completed phase 3 trial tested three doses of the oral drug HRS-7535 against a placebo in 284 adults with type 2 diabetes whose blood sugar was not well controlled by diet and exercise alone. The main goal was to see if HRS-7535 could lower HbA1c (a measure of average blood …
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Weekly shot helps people shed pounds in Year-Long study
Disease control CompletedThis study tested a weekly injection of semaglutide (2.4 mg) to help adults with overweight or obesity lose weight. About 242 people took part, comparing the drug to a placebo over roughly one year. The main goal was to see how much weight they lost and how many lost at least 5% …
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Can a glucose monitor and a phone call help control diabetes?
Disease control CompletedThis study looked at whether giving underserved patients with type 2 diabetes a continuous glucose monitor (CGM) plus monthly telehealth visits with a pharmacist helps them manage their blood sugar better. 46 adults with uncontrolled diabetes took part. Researchers compared those…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Smart insulin pump trial shows promise for type 2 diabetes management
Disease control CompletedThis pilot study tested whether using an automated insulin delivery (AID) system for just 10 days can help people with type 2 diabetes safely adjust their long-acting insulin doses. 23 adults who already used insulin injections took part. The goal was to see if the device was saf…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Intensive insulin strategy may ease diabetes drug burden
Disease control CompletedThis study tested whether a short period of intensive insulin therapy, followed by a combination of basal insulin, metformin, and vildagliptin, could help people with poorly controlled type 2 diabetes simplify their long-term treatment. The goal was to see if more participants co…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE4 • Sponsor: Yanbing Li • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Can a Heart-Healthy diet tame blood pressure in diabetes?
Disease control CompletedThis study looked at whether a DASH-style diet (modified for diabetes) combined with lower salt intake can lower blood pressure in adults with type 2 diabetes and high blood pressure. 105 participants ate specially prepared meals for 5-week periods. The goal was to find a practic…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
App that learns your habits could help tame diabetes
Disease control CompletedThis study tested a smartphone app called T2.coach that tracks diet, blood sugar, activity, and sleep, then uses machine learning to give personalized behavioral goals. About 280 adults with type 2 diabetes and high blood sugar used the app for 6 months alongside standard diabete…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Can meal timing help shift workers beat diabetes?
Disease control CompletedThis study looked at whether three different low-calorie diets could improve blood sugar and body composition in 120 shift workers who are overweight and have prediabetes or type 2 diabetes. Each diet had a different amount and timing of protein. The goal was to see which approac…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Universidad de Zaragoza • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New phone program helps older black adults manage diabetes
Disease control CompletedThis study tested a phone-based program for 100 African Americans aged 50+ with poorly controlled type 2 diabetes. The program combined diabetes education and help with social needs like food or housing. Results aim to show if this approach improves blood sugar control and qualit…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could a probiotic boost weight loss after surgery?
Disease control CompletedThis study tested whether taking a probiotic called Hafnia alvei HA4597 can help people lose more weight and control blood sugar better after gastric bypass surgery. 49 adults with obesity and type 2 diabetes took either the probiotic or a placebo twice a day for 90 days, startin…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Universidade Nova de Lisboa • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Which ketogenic diet works best? new study compares meal replacements vs. natural foods
Disease control CompletedThis study looked at how well adults with obesity or complicated overweight could stick to different very low-calorie ketogenic diets (VLCKD) in a real-world clinic. Participants chose one of four diet plans, ranging from all-natural foods to all meal replacements, and followed a…
Matched conditions: TYPE 2 DIABETES
Sponsor: University of Bologna • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can a gout drug cool down artery inflammation in diabetics?
Disease control CompletedThis study tested whether colchicine, a drug used for gout, can reduce inflammation in the arteries of people with diabetes who recently had a heart attack or stroke. Researchers used a special PET scan to measure inflammation in the blood vessels. 115 participants were randomly …
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Ottawa Heart Institute Research Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New insulin option shows promise for diabetes control
Disease control CompletedThis study tested a new insulin (22011) to see if it works as well as an existing insulin (Ryzodeg) for people with type 2 diabetes. About 414 adults in China took part. The goal was to compare blood sugar control and safety. Results suggest the new insulin is a similar option fo…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New diabetes drug rongliflozin tested in patients with kidney problems
Disease control CompletedThis early study tested a single dose of the drug rongliflozin in 32 Chinese adults with type 2 diabetes who had normal, mildly, or moderately reduced kidney function. Researchers measured how the drug moved through the body and how it affected blood sugar and urine glucose. The …
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Sunshine Lake Pharma Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New phone program aims to help overwhelmed caregivers control diabetes
Disease control CompletedThis pilot study tested a 12-week phone program for 60 African American women aged 40-64 with type 2 diabetes and multiple caregiving responsibilities. Half received extra support for their caregiving stress plus diabetes education, while the other half got standard diabetes educ…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Vitamin B6 shows promise for diabetes blood vessel health
Disease control CompletedThis study tested whether a form of vitamin B6 called pyridoxamine can improve the health of small blood vessels in people with type 2 diabetes. The researchers gave 40 participants either pyridoxamine or a placebo for a period, then switched treatments to compare effects. They m…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Maastricht University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Lifestyle overhaul may ease diabetic nerve pain
Disease control CompletedThis study looked at whether a 12-week intensive lifestyle program focused on weight loss and diabetes control could improve diabetic peripheral neuropathy, a common nerve complication. Fifty adults with diabetes and a BMI between 30 and 45 took part. The program included diet, e…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Joslin Diabetes Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New combo shot CagriSema takes on tirzepatide in diabetes showdown
Disease control CompletedThis study tested a new investigational drug called CagriSema against a currently available medicine, tirzepatide, in over 1,000 adults with type 2 diabetes. The goal was to see which works better at lowering blood sugar and body weight. Participants received weekly injections of…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New daily pill could help control blood sugar in type 2 diabetes
Disease control CompletedThis study tested a once-daily pill called orforglipron in 559 adults with type 2 diabetes whose blood sugar was not well controlled by diet and exercise alone. The pill was compared to a placebo (a dummy pill) over about 54 weeks to see if it safely lowers blood sugar levels. Th…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New daily pill could rival insulin for diabetes and heart risk
Disease control CompletedThis study tested a once-daily pill called orforglipron against insulin glargine in nearly 2,750 adults with type 2 diabetes, obesity or overweight, and increased cardiovascular risk. The main goal was to see if orforglipron could reduce major heart events like heart attacks or s…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Three months of gym training shows promise for blood sugar control
Disease control CompletedThis study looked at whether a 3-month supervised exercise program can improve blood sugar, body fat, and fitness in sedentary men aged 35-65 with type 2 diabetes, prediabetes, or overweight. Participants exercised at a fitness center under supervision. The goal was to see how di…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Medical University of Bialystok • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Pharmacist coaching boosts diabetes control in nigerian hospital study
Disease control CompletedThis study tested whether extra support from a pharmacist can help people with type 2 diabetes manage their blood sugar better. 122 participants were split into two groups: one got usual care, the other got usual care plus regular pharmacist sessions covering medication use, heal…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Maiduguri • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can a common diabetes drug help transplant patients?
Disease control CompletedThis study looked at how sitagliptin (Januvia) affects levels of anti-rejection drugs and blood sugar in 16 people who had a kidney transplant and have type 2 diabetes. Participants took sitagliptin daily for 3 months. The goal was to see if it is safe and works well in this grou…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo shot CagriSema shows promise for diabetes and weight loss
Disease control CompletedThis study tested a new investigational medicine called CagriSema in 189 adults with type 2 diabetes whose blood sugar was not well controlled by diet and exercise alone. Participants received either CagriSema or a placebo injection once a week for about a year. The main goal was…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Mindfulness may curb diabetes risk in depressed teens
Disease control CompletedThis study tested whether a 6-week mindfulness program could help teens at risk for type 2 diabetes by reducing depression and insulin resistance. 120 teens aged 12-17 with overweight, a family history of diabetes, and elevated depression symptoms took part. They were randomly as…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Colorado State University • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Digital diet program aims to remit diabetes in 64 patients
Disease control CompletedThis completed study tested whether a high-intensity medical weight loss program, supported by a digital platform and continuous glucose monitors, could help people with type 2 diabetes lose weight and achieve remission. 64 participants were enrolled and compared to a group recei…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New combo shot shows promise for kidney health in diabetes patients
Disease control CompletedThis study tested whether a new medicine called CagriSema (a combination of two drugs) can reduce kidney damage in people with chronic kidney disease, type 2 diabetes, and overweight or obesity. About 626 participants received either CagriSema, one of the two drugs alone, or a pl…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Phone-Based nurse coaching helps bangladeshi diabetes patients take control
Disease control CompletedThis study tested a telenursing program that gave health education and lifestyle advice to 70 adults with type 2 diabetes in Bangladesh. Participants used their smartphones to get support from nurses on diet, exercise, and medication. The goal was to see if this approach could im…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Hiroshima University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Diabetes drug study reveals hidden genetic links to weight and inflammation
Disease control CompletedThis completed study looked at how two common diabetes drugs, dapagliflozin and empagliflozin, affect weight, cholesterol, and inflammation in 260 obese adults newly diagnosed with type 2 diabetes. Over six months, researchers measured changes in body weight, blood fats, and mark…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE4 • Sponsor: Erbil Polytechnic University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can cooking classes help control diabetes? new study tests virtual program
Disease control CompletedThis study tested a virtual culinary medicine program for 89 adults with type 2 diabetes and elevated body mass index. Participants attended five online cooking and nutrition sessions, learning basic skills and healthy eating habits. Researchers measured changes in blood sugar (H…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Overripe banana powder shows promise for diabetes control
Disease control CompletedThis study tested whether a daily supplement of overripe banana powder can improve blood sugar control in adults with type 2 diabetes. Sixty participants took either the banana supplement or a standard formula for 12 weeks. Researchers measured changes in fasting blood sugar, HbA…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Universiti Sains Malaysia • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New Cloud-Based system could transform diabetes care in hospitals
Disease control CompletedThis study tested a continuous glucose monitor (CGM) that sends real-time blood sugar data to a cloud-based dashboard, allowing a remote team to manage high-risk type 2 diabetes patients in the hospital. Over 500 participants were assigned to either the active CGM system or usual…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Scripps Whittier Diabetes Institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Tuna nuggets show promise for heart health
Disease control CompletedThis study tested whether eating tuna-based nuggets for three months could improve health in 120 people with heart disease and related conditions like obesity and diabetes. The nuggets were given as a source of selenium. Results showed improvements in some markers of inflammation…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Lahore Hospital (ULH) • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a phone app and smart sensor tame blood sugar? new study says maybe.
Disease control CompletedThis study looked at whether using a mobile app called Undermyfork along with a continuous glucose monitor (Dexcom G7) helps people with type 2 diabetes control their blood sugar better than standard care. About 91 adults with type 2 diabetes who were not on rapid-acting insulin …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Scripps Whittier Diabetes Institute • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
New CGM algorithm could simplify insulin dosing for diabetes
Disease control CompletedThis pilot study tested a new computer algorithm that uses continuous glucose monitor (CGM) readings to automatically suggest the right dose of long-acting insulin for people with type 2 diabetes. Thirty adults already using basal insulin were followed for 18 weeks to see if the …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Which diabetes pill is better for Early-Stage patients? major trial compares dapagliflozin and metformin
Disease control CompletedThis study compared two common diabetes drugs—dapagliflozin and metformin—in over 2,000 people with early type 2 diabetes (diagnosed less than 4 years). The goal was to see which drug better prevents serious complications like death, heart attack, stroke, heart failure, kidney di…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE4 • Sponsor: Uppsala University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Liver transplant diabetes study tests which drug better fights fatty liver
Disease control CompletedThis study looked at 100 liver transplant patients with diabetes to see if dapagliflozin or sitagliptin is better at reducing liver fat and improving body composition. Participants took one of the two drugs for 12 months. The goal was to find a safer and more effective way to man…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Medanta, The Medicity, India • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can a smartphone app help tame diabetes? new study puts MoDD to the test
Disease control CompletedThis study tested a web-based app called Mobile Diabetes Detective (MoDD) in 248 adults with type 2 diabetes. The app helps users identify problems with blood sugar control and suggests better behaviors. Researchers measured changes in blood sugar (HbA1c), problem-solving skills,…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New diabetes pill tested in chinese patients – early safety results expected
Disease control CompletedThis early-stage study tested a new daily pill called LY3549492 in 36 Chinese adults with type 2 diabetes. The main goal was to check safety and side effects over about 18 weeks. Participants had diabetes for at least 6 months and were on diet, exercise, or stable metformin. This…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Could a new stomach surgery help control diabetes in gastric cancer patients?
Disease control CompletedThis study tested whether a longer intestinal bypass during stomach cancer surgery improves diabetes control better than the standard method. It included 94 adults with early-stage gastric cancer and type 2 diabetes. Researchers measured blood sugar and hormone levels one year af…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Korea University Guro Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New study tests two ways to improve health in black adults with obesity
Disease control CompletedThis pilot study tested two approaches to improve metabolic health in Black adults with stage 1 obesity and conditions like high blood pressure or prediabetes. Participants received either weight-focused or weight-neutral health coaching for 7 weeks. The goal was to see if a larg…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Tiny sensor tracks blood sugar in kidney transplant patients
Disease control CompletedThis study looked at whether a continuous glucose monitor (CGM) can help track blood sugar levels in 20 people with type 2 diabetes who had a kidney transplant. Participants wore a small sensor that measured glucose around the clock. The goal was to see how often blood sugar stay…
Matched conditions: TYPE 2 DIABETES
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Healthy meals as medicine: new study tests food support for diabetes
Disease control CompletedThis study tested whether providing six months of diabetes-tailored meals and nutrition counseling can improve blood sugar control and reduce food insecurity in adults with type 2 diabetes. 281 participants received either the food support plus counseling or usual care. The main …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New home program helps seniors control diabetes
Disease control CompletedThis study tested a home-based behavioral program called Home DM-BAT for low-income seniors with type 2 diabetes. Two hundred Black or Hispanic seniors aged 65 and older took part. The program involved 8 weekly in-home sessions and monthly booster calls to help improve blood suga…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Patch pump could simplify diabetes care
Disease control CompletedThis study tested a new insulin patch pump in 161 adults with type 1 or type 2 diabetes who needed intensive insulin therapy. Participants used either the new patch pump or a standard pump for 7 days in a hospital. Researchers measured changes in average blood sugar levels to see…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Suzhou Hechun Medical Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Smartphone app aims to tame diabetes with personalized lifestyle tips
Disease control CompletedThis completed study tested an AI-based system called X-Life that gives personalized lifestyle advice to adults with type 2 diabetes. The system uses glucose levels and wearable data to guide diet and activity. 124 participants were split into two groups: one using X-Life and the…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Li Huating • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Massive study reveals best diabetes drug combinations
Disease control CompletedThis study compared several common diabetes medications when added to metformin in 7,850 adults with type 2 diabetes. The goal was to see which combination best kept blood sugar under control over time. Results help doctors and patients choose the most effective treatment plan.
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: GRADE Study Group • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Can a digital weight program and glucose monitor help control diabetes?
Disease control CompletedThis study tested whether a virtual weight control program combined with a continuous glucose monitor could help adults with type 2 diabetes lower their blood sugar levels. 152 overweight or obese adults with type 2 diabetes participated. The program used the WW (Weight Watchers)…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Pennington Biomedical Research Center • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New patch could replace fingersticks for 5 days of glucose monitoring
Disease control CompletedThis study tested a small, wearable sensor that sits just under the skin and measures blood sugar continuously for up to 5 days in adults with diabetes. 247 participants wore the sensor along with a standard monitor and took fingerstick tests to compare accuracy. The goal was to …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Biolinq Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can a 'Garbage and Lorry' analogy improve diabetes control?
Disease control CompletedThis completed study tested whether a new consultation method called M2-PRIME, which uses simple analogies like the 'Garbage and Lorry' model, could help people with type 2 diabetes on insulin improve their blood sugar control. 106 participants received three analogy-based consul…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Ministry of Health, Malaysia • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New combo shot helps east asians shed pounds in major trial
Disease control CompletedThis study tested a new medicine called CagriSema (a mix of two drugs) in 331 East Asian adults with obesity or overweight. Participants received a weekly injection for about 1.5 years. The main goal was to see how much weight they lost compared to another drug. The study is comp…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New smart insulin pump shows promise for diabetes control
Disease control CompletedThis study tested the safety and effectiveness of the Omnipod 5 SmartAdjust 2.0 system, an automated insulin pump, in 48 people aged 2 to 70 with type 1 or type 2 diabetes. The system uses a continuous glucose monitor to automatically adjust insulin delivery. The main goals were …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Could a gut lining 'Reset' help tame diabetes?
Disease control CompletedThis study tested a new device, DyaMX, that uses an endoscope to regenerate the lining of the upper small intestine in people with type 2 diabetes. The goal was to see if the procedure is safe and can help improve blood sugar control. 65 adults with diabetes took part. The main f…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Endogenex, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Weight loss pill shows promise in chinese adults: phase 3 trial complete
Disease control CompletedThis study tested whether a daily semaglutide tablet helps Chinese adults with overweight or obesity lose weight. About 200 participants took either the drug or a placebo for 44 weeks, along with guidance on diet and exercise. The main goals were to measure the percentage of weig…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Cash and coaching boost diabetes control in new study
Disease control CompletedThis study tested a program that combines diabetes coaching, small financial rewards, and continuous glucose monitoring to help adults with type 2 diabetes improve their blood sugar management. 26 participants used a continuous glucose monitor and received motivational interviews…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Missouri, Kansas City • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New diabetes drug shows promise in early trial
Disease control CompletedThis study tested an experimental drug, MCI-196, in 183 people with type 2 diabetes to see if it could help control blood sugar and improve cholesterol levels. Participants took the drug or a placebo for 12 weeks. The goal was to measure changes in blood glucose and HbA1c, a key …
Matched conditions: TYPE 2 DIABETES
Phase: PHASE2 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Video-Call workouts tested for diabetes management
Disease control CompletedThis study looked at whether doing calisthenic exercises (like bodyweight moves) through video calls with a physiotherapist could improve oxygen use, muscle health, and physical activity in adults with type 2 diabetes. Forty participants completed the program, exercising 30-45 mi…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Gazi University • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New diabetes pill shows promise in early trial
Disease control CompletedThis phase 2 study tested a new drug called teneligliptin (MP-513) in 324 Japanese adults with type 2 diabetes. Participants took one of three doses of the drug or a placebo daily for 12 weeks. The main goal was to see how well the drug lowered blood sugar levels (HbA1c) and to c…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE2 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Which diet best tames type 2 diabetes? mediterranean, DASH, or MIND?
Disease control CompletedThis study looked at how three popular diets—Mediterranean, DASH, and MIND—affect blood sugar, cholesterol, and body measurements in people with type 2 diabetes. 90 adults completed surveys and had their weight, waist size, and lab values measured. The goal was to see which eatin…
Matched conditions: TYPE 2 DIABETES
Sponsor: Abant Izzet Baysal University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Cooking method matters: simple diet change shows promise for diabetes and heart health
Disease control CompletedThis completed trial tested a low-AGE diet in 36 adults aged 55-65 with type 2 diabetes, coronary artery disease, and overweight. Participants were instructed to boil or steam food instead of frying, grilling, or roasting. The diet reduced blood levels of a harmful compound calle…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: InCor Heart Institute • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Magnetic gut reroute shows promise for diabetes and weight loss
Disease control CompletedThis study tested a new magnetic system that creates a shortcut in the small intestine to help people with obesity and type 2 diabetes. Fifteen adults aged 18-65 with a BMI of 30-35 and diabetes took part. The goal was to see if the device could safely create a lasting connection…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: GT Metabolic Solutions, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Glucose alerts tested in hospital diabetes study
Disease control CompletedThis study looked at whether alerts from continuous glucose monitors (CGMs) help hospital patients with type 1 or 2 diabetes manage their blood sugar better. Over 500 adults who needed intensive insulin therapy took part. The main goal was to see if alerts increased the time bloo…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Shanghai 6th People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New insulin candidate tested in 1,040 chinese diabetes patients
Disease control CompletedThis study tested a new insulin called THDB0206 against a standard insulin (lispro) in 1,040 Chinese adults with type 2 diabetes. Both were used alongside a long-acting insulin. The goal was to see if the new insulin works as well or better at controlling blood sugar over 26 week…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Tonghua Dongbao Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Magnet surgery: a new way to treat obesity and diabetes?
Disease control CompletedThis study tested a new magnetic device that creates a connection between two parts of the small intestine, bypassing some of the digestive tract. The goal was to see if this procedure is safe and feasible for adults with obesity and type 2 diabetes. Only 9 people took part, and …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: GT Metabolic Solutions, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New insulin pump aims to keep blood sugar in check with fewer mealtime shots
Disease control CompletedThis study compared a new version of the Omnipod insulin pump (SmartAdjust 2.0) to the current Omnipod 5 in 132 people with type 1 or type 2 diabetes, ages 2 to 70. Participants used each system for about a month to see if the new one is safe and helps keep blood sugar in a healt…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New diabetes program aims to help those with disabilities manage their condition
Disease control CompletedThis study tested a special diabetes education program for adults with type 2 diabetes and physical disabilities. The program included health coaching and educational materials, either through a tech platform or email. Researchers measured quality of life, distress, and self-conf…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Nurse-Led diabetes support boosts breast cancer care
Disease control CompletedThis study looked at whether adding a nurse trained in diabetes care to the treatment team helps breast cancer patients with diabetes or prediabetes manage their blood sugar during cancer therapy. Researchers split 74 patients into two groups: one worked with the diabetes nurse, …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a phone call and a community referral help older adults control diabetes?
Disease control CompletedThis completed trial tested two programs for older adults with type 2 diabetes: one with monthly phone coaching and one that added personalized referrals to community resources. Over 500 participants were followed for a year to see if these approaches helped lower blood sugar lev…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Diabetes drug may fight heart scarring in High-Risk patients
Disease control CompletedThis completed study tested whether canagliflozin, a diabetes drug, can reduce scarring in the heart muscle of people with type 2 diabetes who are at high risk for heart problems. 45 participants were randomly assigned to take either canagliflozin or sitagliptin daily. Researcher…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE4 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a natural protein help control blood sugar in type 2 diabetes?
Disease control CompletedThis early study tested whether a protein called apelin can improve how the body uses insulin in people with type 2 diabetes. Nine volunteers received both apelin and a placebo infusion to compare effects. The goal was to see if apelin increases the amount of sugar the body can p…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Generic diabetes pill put to the test against Brand-Name drug
Disease control CompletedThis study checked if a new generic pill for type 2 diabetes (ertugliflozin/metformin) works the same as the brand-name drug (Segluromet). Thirty-six healthy adults took a single dose of each pill in random order. The goal was to see if the body absorbs both drugs at similar leve…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Humanis Saglık Anonim Sirketi • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
New diabetes drug HRS-7535 shows promise in early trial
Disease control CompletedThis Phase 2 trial tested a new drug called HRS-7535 in 155 adults with type 2 diabetes whose blood sugar was not well controlled despite taking metformin and an SGLT2i. Participants received either HRS-7535 or a placebo for 16 weeks. The main goal was to see if the drug could lo…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE2 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Frequent Follow-Up may boost diabetes control
Disease control CompletedThis study looked at whether regular follow-up visits with nurses and dietitians help people with type 2 diabetes manage their condition better. 398 adults with type 2 diabetes first received a week of education on diet and exercise. Then half were assigned to frequent check-ins …
Matched conditions: TYPE 2 DIABETES
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New combo shot CagriSema shows promise for diabetes and weight loss
Disease control CompletedThis study tested a new investigational medicine called CagriSema, which combines two drugs (cagrilintide and semaglutide) in one weekly injection. It was given to 274 adults with type 2 diabetes who were already taking daily insulin, with or without metformin. The goal was to se…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New pill CT-996 tested for obesity and diabetes – early results promising?
Disease control CompletedThis early-stage trial tested a new drug called CT-996 in 94 overweight or obese adults, including some with type 2 diabetes. The main goal was to check safety and how the body processes the drug. Researchers gave single or multiple doses and monitored side effects. This is a fir…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Carmot Australia First Pty Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a common gut supplement boost weight loss in diabetes?
Disease control CompletedThis study tested whether taking sodium butyrate tablets for 12 weeks, along with a modestly reduced-calorie diet, helps overweight or obese adults (with or without type 2 diabetes) lose more weight and improve blood sugar and fat levels compared to a placebo. 46 participants wer…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Federico II University • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Could a weight-loss drug also shield kidneys? new study explores retatrutide for CKD patients.
Disease control CompletedThis study tested whether retatrutide, a medication being studied for weight loss, can help preserve kidney function in 146 adults who are overweight or obese and have chronic kidney disease (with or without type 2 diabetes). Participants received the drug or a placebo for about …
Matched conditions: TYPE 2 DIABETES
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Breakfast makeover: simple diet change may tame diabetes
Disease control CompletedThis study tested a 4-month online program that encourages a very low-carbohydrate breakfast for adults with poorly controlled type 2 diabetes. Researchers measured how satisfied participants were, how well they stuck to the diet, and changes in blood sugar, weight, and medicatio…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Smart insulin pump could transform hospital diabetes care
Disease control CompletedThis study tested an automated insulin delivery system (the Omnipod 5) in 130 hospitalized adults with type 1 or type 2 diabetes. Patients were randomly assigned to use the automated system or standard insulin injections plus a continuous glucose monitor. The goal was to see if t…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Keto diet battles plate method for diabetes control
Disease control CompletedThis study compared two diets for people with type 2 diabetes: a very low-carbohydrate (keto) diet and a plate-method diet. Over 12 months, researchers tracked blood sugar control and body composition in 182 participants. The goal was to see which approach better improves diabete…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New app helps diabetes patients stay on track with insulin
Disease control CompletedThis study tested a connected insulin management platform in 36 people with type 1 or type 2 diabetes who use insulin. The goal was to see if the platform helped them take their insulin doses on time and keep their blood sugar in a healthy range. Participants used a continuous gl…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
Fasting your way to better blood sugar? new study tests two diet plans
Disease control CompletedThis study tested whether two types of intermittent fasting—eating very little a few days a week or eating only during an 8-hour window—can help people with type 2 diabetes improve their blood sugar control. Fifty-seven adults with diabetes followed one of these diet plans for a …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Kansas Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New diabetes drug tirzepatide tested in chinese patients
Disease control CompletedThis Phase 3 trial tested the drug tirzepatide (a once-weekly injection) against a placebo in 206 Chinese adults with type 2 diabetes. The goal was to see if tirzepatide could safely lower blood sugar levels. Participants had to have stable weight and a BMI of 23 or higher. The s…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New daily pill aims to improve blood sugar in type 2 diabetes
Disease control CompletedThis study tested a once-daily pill called orforglipron in 546 adults with type 2 diabetes whose blood sugar was not well controlled despite using insulin (with or without other diabetes medications). The goal was to see if adding orforglipron could safely lower blood sugar level…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Community program helps native hawaiians take control of high blood pressure
Disease control CompletedThis study tested a program called ENACTS to help Native Hawaiian and Pacific Islander adults with high blood pressure or type 2 diabetes lower their blood pressure. The program included support for healthier eating, more physical activity, and working with grocery stores to labe…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Washington State University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New daily pill aims to beat standard diabetes drug in blood sugar battle
Disease control CompletedThis study tested a new once-daily pill called orforglipron against an existing drug, dapagliflozin, in adults with type 2 diabetes whose blood sugar was not well controlled with metformin alone. About 962 participants took either orforglipron or dapagliflozin for roughly 46 week…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Flaxseed oil shows promise for blood sugar control
Disease control CompletedThis study tested whether taking flaxseed oil capsules (rich in alpha linolenic acid) for 24 weeks could improve blood sugar levels in 94 adults with elevated blood sugar or mild type 2 diabetes. Participants also had their gut bacteria and fatty acids measured. The goal was to s…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Smart insulin pump shows promise for type 2 diabetes control
Disease control CompletedThis study tested the Omnipod 5, a wearable device that automatically delivers insulin, in 343 adults with type 2 diabetes. Participants used the system for 13 weeks to see if it improved blood sugar levels. The goal was to make diabetes management simpler and more effective.
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Insulet Corporation • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New Long-Acting diabetes shot shows promise in first human test
Disease control CompletedThis early study tested a single injection of NEX-22A, a long-acting version of the diabetes drug liraglutide, in 12 adults with type 2 diabetes. The main goal was to see how the drug moves through the body and if it is safe. Participants were on stable metformin therapy and rece…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Nanexa AB • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New diabetes pill takes on semaglutide in Head-to-Head trial
Disease control CompletedThis phase 3 study tested a new once-daily pill called orforglipron against an existing oral semaglutide in nearly 1,700 adults with type 2 diabetes whose blood sugar was not well controlled on metformin. The main goal was to see how well orforglipron lowers blood sugar levels ov…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can exercise strengthen bones in diabetic women after menopause?
Disease control CompletedThis study looked at whether moderate aerobic exercise or resistance exercise is better for improving bone density in postmenopausal women with type 2 diabetes and osteoporosis. Fifty women aged 50-60 did either treadmill walking or resistance training three times a week for 12 w…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Deraya University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New daily pill could help people with obesity and diabetes shed pounds
Disease control CompletedThis phase 3 study tested an experimental once-daily pill called orforglipron (LY3502970) against a placebo in 1613 adults who are overweight or have obesity and type 2 diabetes. The goal was to see if the drug helps with weight loss and improves blood sugar control. Participants…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 26, 2026 18:35 UTC
-
Magnesium pills may improve blood sugar in type 2 diabetes
Disease control CompletedThis study tested whether taking magnesium oxide tablets (500 mg daily) for up to 12 months could improve blood sugar control in adults with type 2 diabetes. Researchers measured changes in HbA1c and fasting blood glucose, and tracked hospital visits. The goal was to see if magne…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Sultan Qaboos University • Aim: Disease control
Last updated Jun 26, 2026 18:10 UTC
-
Could mangosteen help control type 2 diabetes?
Disease control CompletedThis study tested whether adding a mangosteen supplement to standard diabetes drugs (sitagliptin/metformin) improves blood sugar control in 47 adults with type 2 diabetes. Participants took either the standard drugs alone or with mangosteen for 12 weeks. Researchers measured chan…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Mais Qais Hbeeb • Aim: Disease control
Last updated Jun 26, 2026 17:08 UTC
-
Rural india pregnancy trial tests simple screening to save mothers
Disease control CompletedThis trial tested a program where community health workers used a tablet app to screen pregnant women in rural India for anemia, high blood pressure, and diabetes. Over 3,400 women took part. The goal was to see if this screening and referral system could lower anemia rates and i…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: The George Institute • Aim: Disease control
Last updated Jun 26, 2026 16:55 UTC
-
Can pilates and coaching help seniors with diabetes? new study says maybe
Disease control CompletedThis study looked at whether combining clinical Pilates, nurse coaching, and peer group work could improve general health in older adults with type 2 diabetes. 48 people aged 65 and older were split into four groups and followed for 12 weeks. Researchers measured things like anxi…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Hacettepe University • Aim: Disease control
Last updated Jun 26, 2026 15:47 UTC
-
Diet soda vs. water: which is better for blood sugar?
Disease control CompletedThis study looked at whether drinking diet beverages (like diet soda) instead of water affects blood sugar control in adults with type 2 diabetes. 181 participants who regularly drank diet beverages were randomly assigned to keep drinking them or switch to plain water for 24 week…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of California, Irvine • Aim: Disease control
Last updated Jun 26, 2026 15:38 UTC
-
Gut health boost: synbiotics show promise for diabetes management
Disease control CompletedThis study tested whether taking a synbiotic (a mix of probiotics and prebiotics) for 6 months could improve blood sugar control, reduce inflammation, and change body composition in adults with prediabetes or type 2 diabetes. Researchers recruited 64 participants from a hospital …
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Imam Abdulrahman Bin Faisal University • Aim: Disease control
Last updated Jun 26, 2026 14:28 UTC
-
AI model could spare diabetes patients from invasive kidney biopsies
Diagnosis CompletedThis study uses machine learning to tell apart diabetic kidney disease from other kidney diseases in people with type 2 diabetes. Researchers analyzed data from over 2,200 patients across 14 medical centers to build a model that uses routine clinical and lab information. The goal…
Matched conditions: TYPE 2 DIABETES
Sponsor: Beijing Tongren Hospital • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Talking to your phone could detect diabetes, study finds
Diagnosis CompletedThis study tested whether computer analysis of voice recordings can detect type 2 diabetes. Over 7,000 adults in the UK recorded themselves reading and answering questions online. A subset also provided blood samples to check accuracy. The goal is to see if voice biomarkers could…
Matched conditions: TYPE 2 DIABETES
Sponsor: Thymia Limited • Aim: Diagnosis
Last updated Jun 27, 2026 11:03 UTC
-
Painless glucose check? new device could end finger pricks
Diagnosis CompletedThis study tested a new device called the Cmate blood glucose analyzer, which measures blood sugar without needing a finger prick. Researchers compared its readings to standard blood tests in 40 healthy, pre-diabetic, and diabetic adults. The goal is to see if this non-invasive m…
Matched conditions: TYPE 2 DIABETES
Sponsor: Revlis Biotech Company Limited • Aim: Diagnosis
Last updated Jun 27, 2026 08:14 UTC
-
Digital family program aims to curb diabetes and hypertension across europe
Prevention CompletedThis completed study tested a 24-month program that combined face-to-face counseling with digital tools to help families prevent and manage type 2 diabetes and high blood pressure. Over 1,200 adults and their children from Albania, Bulgaria, Greece, and Spain took part. The progr…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Harokopio University • Aim: Prevention
Last updated Jun 27, 2026 13:05 UTC
-
Fitbit and DNA test team up to fight diabetes in At-Risk asians
Prevention CompletedThis study looked at whether telling overweight East Asians their genetic risk for type 2 diabetes, combined with using a Fitbit, could encourage them to be more active. 355 participants aged 40-60 were split into groups: some got just a Fitbit, others got their genetic risk plus…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: The University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Massive study tests if daily pills can ward off diabetes
Prevention CompletedThis study looked at whether taking vitamin D or fish oil supplements every day can help prevent type 2 diabetes. Over 22,000 adults without diabetes took part. Researchers tracked who developed diabetes over time to see if the supplements made a difference.
Matched conditions: TYPE 2 DIABETES
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
New program helps men beat diabetes risk
Prevention CompletedThis study tested a special version of the Diabetes Prevention Program designed specifically for men. 301 men with pre-diabetes or high risk took part to see if the program helped them lose weight and prevent type 2 diabetes. The program focused on lifestyle changes and was deliv…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Albert Einstein College of Medicine • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
Phone app aims to curb diabetes in rural hispanic populations
Prevention CompletedThis study tested a mobile, web-based program called STEPS to help prevent type 2 diabetes in Hispanic adults living in rural areas. 179 participants at high risk for prediabetes were randomly assigned to use STEPS or receive usual care for three months. Researchers measured weig…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: ISA Associates, Inc. • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Puzzles and plate method: new workbook aims to boost diabetes confidence
Symptom relief CompletedThis pilot study tested a word game-based workbook to help people with diabetes learn about managing their condition, focusing on diet and carbohydrate control. 25 participants used the workbook during clinic visits or at home, completing puzzles and goal-setting exercises. The s…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Emory University • Aim: Symptom relief
Last updated Jul 02, 2026 00:00 UTC
-
Mindfulness program tested to tackle diabetes distress
Symptom relief CompletedThis pilot study tested a mindfulness-based diabetes education program for adults with type 2 diabetes who feel overwhelmed by their condition. Thirty-six participants were randomly assigned to either the mindfulness program or standard diabetes education. The main goal was to se…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Simple relaxation exercises show promise for diabetes symptoms
Symptom relief CompletedThis study looked at whether progressive relaxation exercises can help people with type 2 diabetes who have nerve pain, fatigue, and poor sleep. 88 adults took part. The goal was to see if these simple exercises could improve their symptoms and quality of life.
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Ataturk University • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Electric shocks may replace exercise for diabetes patients
Symptom relief CompletedThis study tested whether using electrical stimulation on the thigh muscles could improve how the body uses insulin in people with type 2 diabetes. Eighteen adults with type 2 diabetes who were overweight and on oral medication received a single session and then six days of daily…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University Hospital, Caen • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Exercise program aims to reverse frailty in seniors with diabetes
Symptom relief CompletedThis study tested whether a 6-month exercise program called Vivifrail could improve physical function, thinking skills, and quality of life in 80 older adults (ages 60-80) with type 2 diabetes and frailty. Participants exercised three times a week, with increasing intensity over …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: National Geriatric Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Ancient exercise shows promise for diabetes management
Symptom relief CompletedThis study tested whether Baduanjin, a traditional Chinese exercise that combines gentle movements with mindful breathing, can help people with type 2 diabetes. 42 adults aged 50-60 with diabetes for 5-10 years took part. Researchers measured changes in blood sugar, quality of li…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
Can a diabetes drug ease nerve pain? new study tests acarbose with smart glucose monitoring
Symptom relief CompletedThis study tested whether the diabetes drug acarbose, adjusted using continuous glucose monitoring (CGM), can reduce pain in adults with painful diabetic neuropathy. 170 participants with type 2 diabetes and high blood sugar swings were enrolled. The goal was to see if controllin…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Shifa International Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Specialty coffee may sharpen minds of people with diabetes
Symptom relief CompletedThis study looked at whether drinking specialty coffee (a type high in a natural compound called chlorogenic acid) could improve memory, thinking speed, and attention in people with type 2 diabetes. Forty coffee drinkers with diabetes took part, drinking either specialty or regul…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Reading • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Can a smartphone app help people with food insecurity stop binge eating?
Symptom relief CompletedThis pilot study tested a digital program called FoodSteps for adults who struggle with binge eating, have type 2 diabetes, and face food insecurity. Participants used a mobile app and received coaching and a weekly stipend for 16 weeks. The goal was to see if the program is feas…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Northwestern University • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Sweet gummy, sharp results: maqui berry may tame blood sugar spikes
Symptom relief CompletedThis small study tested whether gummy candies made with maqui berry could help overweight adults control their blood sugar after eating a carb-rich meal. Ten participants ate white bread alone, or with maqui berry gummies, and had their blood sugar and antioxidant levels measured…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Gonzalo Jorquera, PhD • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New Weight-Loss drug AZD5004 tested in chinese adults
Symptom relief CompletedThis early-stage study tested a new drug called AZD5004 in 45 Chinese adults who were overweight or had obesity, with or without type 2 diabetes. The main goal was to check if the drug is safe and how the body processes it, compared to a placebo. Participants took the drug or a d…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Eccogene • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Mindfulness program for teens with diabetes shows promise
Symptom relief CompletedThis study tested a mindfulness program for 30 teens aged 12-18 with prediabetes or type 2 diabetes. The goal was to see if the program was practical and liked by teens, and to explore any effects on health measures like blood sugar. The approach involved group sessions and quest…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Easy home exercise may boost blood flow in diabetic patients
Symptom relief CompletedThis study tested whether Buerger-Allen exercises, a series of leg movements done at home twice daily, can improve blood flow in people with type 2 diabetes. Researchers compared 74 participants who did the exercises plus routine care against those who only received routine care.…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Health Sciences Lahore • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Texts and cash incentives get teens moving in prediabetes study
Symptom relief CompletedThis study tested whether daily text messages and small financial rewards could motivate overweight teens and young adults with prediabetes or type 2 diabetes to be more physically active. 75 participants wore a Fitbit and received different combinations of texts and incentives o…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Pittsburgh • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
New coaching program eases diabetes stress for veterans
Symptom relief CompletedThis study tested a phone-based coaching program for veterans with type 2 diabetes who feel stressed or overwhelmed by daily self-care tasks like checking blood sugar and taking insulin. The program gave personalized advice and support to help reduce that stress and improve blood…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
Board game beats boredom: new study tests fun way to tackle diabetes anxiety
Symptom relief CompletedThis study tested whether playing a board game called 'Let's Learn Diabetes' could lower anxiety and help people with type 2 diabetes better follow their insulin treatment. 72 adults aged 40-65 who recently started insulin were randomly assigned to either four weekly game session…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Izmir Tinaztepe University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can a senior center program help older adults with diabetes move better?
Knowledge-focused CompletedThis study tests whether a lifestyle program held at senior centers can help older adults (age 60+) with type 2 diabetes improve their physical function and quality of life. About 20 participants will take part in the program, which includes education and activity sessions. The m…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Could adding a second diabetes drug early save lives?
Knowledge-focused CompletedThis study analyzed health records from over 450,000 adults with obesity and type 2 diabetes to see if adding a GLP-1 or SGLT2 drug early improves survival and kidney health. Researchers compared those who added the other drug class within 90 days to those who added a different d…
Matched conditions: TYPE 2 DIABETES
Sponsor: Chung Shan Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Scientists hunt for diabetes genes in west africa
Knowledge-focused CompletedThis study looked at the genes and lifestyle of over 7,400 people in Nigeria to understand why some develop type 2 diabetes. Researchers compared people with and without diabetes to find genetic differences. The goal is to learn more about diabetes causes in African populations a…
Matched conditions: TYPE 2 DIABETES
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Diabetes Drug's hidden effect on heart fat revealed
Knowledge-focused CompletedThis study looked at how a diabetes medicine called ertugliflozin affects fat tissue around the heart. Researchers took fat samples from 61 adults with type 2 diabetes and heart disease during heart surgery. They tested the fat in a lab to see if the drug improved how the fat cel…
Matched conditions: TYPE 2 DIABETES
Phase: EARLY_PHASE1 • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Can exercise protect diabetic joints? new study investigates
Knowledge-focused CompletedThis study looked at how quickly bringing high blood sugar under control, combined with moderate treadmill walking, affects certain proteins linked to bone health in people with type 2 diabetes. The goal was to understand why some patients develop a rare but serious joint conditi…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Diabetes study reveals hidden health burdens in egyptian city
Knowledge-focused CompletedThis study looked at 295 adults with type 2 diabetes in Kharga City, Egypt, to see how many also had other conditions like high blood pressure, heart disease, kidney disease, or eye problems. Researchers used blood tests, urine tests, and heart tracings to check for these issues.…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: New Valley University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Scientists hunt for genetic clues behind diabetic foot complication
Knowledge-focused CompletedThis study looked at the genes of 40 adults with type 2 diabetes to find DNA differences that might explain why some develop Charcot foot, a serious joint problem. Half of the participants had Charcot foot, and half did not. Researchers compared their exomes (the part of DNA that…
Matched conditions: TYPE 2 DIABETES
Sponsor: Centre Hospitalier Sud Francilien • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Your genes, your diet: a new way to stop diabetes?
Knowledge-focused CompletedThis study looked at 115 adults with prediabetes to understand why different people develop the condition. Researchers tested how each person's body responds to different foods, aiming to create personalized diet plans that prevent diabetes. The goal was to find biological marker…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Blood sugar rollercoaster in frail seniors: which insulin works best?
Knowledge-focused CompletedThis study looked at how much blood sugar levels go up and down during the day in frail or disabled patients over 75 with diabetes who use basal insulin. Researchers used a continuous glucose monitor for 5 days to compare two types of insulin: human NPH and long-acting analogues.…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
5,000 diabetes patients surveyed to uncover health literacy gaps
Knowledge-focused CompletedThis completed study surveyed over 4,600 people living with type 2 diabetes and multiple health conditions, along with their family members, to identify their health literacy strengths and needs. Participants answered a 44-question questionnaire about how well they understand and…
Matched conditions: TYPE 2 DIABETES
Sponsor: University of Southern Denmark • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Scientists probe Fat-Immune link in rare and common metabolic diseases
Knowledge-focused CompletedThis completed study looked at 126 people with different fat distribution patterns—including those with lipodystrophy (abnormal fat loss or distribution), obesity, and normal weight—to understand how fat tissue relates to insulin resistance and immune signals. Researchers measure…
Matched conditions: TYPE 2 DIABETES
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Common diabetes drug may boost survival in septic shock
Knowledge-focused CompletedThis study looked back at medical records of 2,740 adults with type 2 diabetes who were admitted to the ICU for septic shock, a life-threatening infection. Researchers wanted to see if those who were already taking metformin (a standard diabetes pill) before getting sick had a lo…
Matched conditions: TYPE 2 DIABETES
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Massive study pits tirzepatide against rivals for heart protection
Knowledge-focused CompletedThis completed study looked at insurance claims data from 70,000 people with type 2 diabetes and established heart disease to compare the heart-related risks of three diabetes drugs: tirzepatide, dulaglutide, and semaglutide. The goal was to see if any of these drugs was linked t…
Matched conditions: TYPE 2 DIABETES
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
Gut check: can exercise change your diabetes bacteria?
Knowledge-focused CompletedThis study looked at how different levels of exercise change the bacteria in the gut of people with type 2 diabetes. Forty adults with type 2 diabetes did either moderate or high-intensity endurance and strength training for 16 weeks. Researchers compared changes in blood sugar a…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of New Brunswick • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Breath-Holding test reveals glucose secrets
Knowledge-focused CompletedThis study looked at how short periods of low oxygen (from holding your breath) affect blood sugar levels after drinking a sugary drink. Researchers tested 20 healthy adults, people with prediabetes, and people with type 2 diabetes. The goal was to learn more about how oxygen lev…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Texas at Austin • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New care model tested to ease young adults' diabetes transition
Knowledge-focused CompletedThis study tested a new way to help young adults (ages 18-30) with type 1 or type 2 diabetes move from pediatric to adult diabetes care. Researchers compared a collaborative care model to usual care, looking at how many visits patients completed and changes in diabetes-related di…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Kidney function may change how diabetes drug works
Knowledge-focused CompletedThis study looks at how the body processes HRS9531, an experimental diabetes drug, in people with different levels of kidney function. Researchers gave a single dose to 32 volunteers—some with healthy kidneys and some with mild impairment—and measured drug levels over time. The g…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
Could group doctor visits help teens manage diabetes?
Knowledge-focused CompletedThis study looked at whether shared medical appointments—where teens with type 2 diabetes meet together with their care team—are an acceptable way to deliver care. Researchers designed four group activities focused on nutrition, peer support, exercise, and stress management, and …
Matched conditions: TYPE 2 DIABETES
Sponsor: Children's Hospital Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New app aims to help chronic patients breathe easier while walking
Knowledge-focused CompletedThis study tested how easy and acceptable the P-STEP mobile app is for people with chronic conditions like asthma, COPD, heart disease, or diabetes. 178 adults in Leicester, UK used the app for 12 weeks to track their walking and get air quality updates. The main goal was to meas…
Matched conditions: TYPE 2 DIABETES
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Big data reveals diabetes and weight swings impact heart failure survival
Knowledge-focused CompletedThis study analyzed data from over 16,500 adults with chronic heart failure who were part of a remote monitoring program in France. Researchers looked at how having diabetes, other health conditions, and short-term weight changes were linked to survival. The goal was to better un…
Matched conditions: TYPE 2 DIABETES
Sponsor: Satelia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
ER alerts may help tame type 2 diabetes
Knowledge-focused CompletedThis completed trial tested whether electronic alerts in the emergency room can improve care for people with type 2 diabetes. The alerts prompted doctors to order an A1c test when blood sugar was very high, and to consider admitting the patient for better diabetes management. Res…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Rutgers, The State University of New Jersey • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
New approach aims to catch kidney disease earlier in hispanic and black communities
Knowledge-focused CompletedThis study worked with community groups to screen Hispanic/Latinx adults for kidney disease and diabetes, then referred them to a primary care doctor. It also gave local clinics guidelines to help doctors screen and treat Hispanic and Black patients with diabetes. The goal was to…
Matched conditions: TYPE 2 DIABETES
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Belly fat measurement showdown: tape measure vs. High-Tech scale
Knowledge-focused CompletedThis study looked at two easy methods to measure hidden belly fat in 110 adults with type 2 diabetes. Researchers compared a simple waist measurement to a device that sends a mild electrical signal through the body. The goal was to see which method better relates to heart disease…
Matched conditions: TYPE 2 DIABETES
Sponsor: Joslin Diabetes Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a wearable glucose monitor keep hospital patients safer?
Knowledge-focused CompletedThis pilot study tested whether continuous glucose monitors (CGMs) can help manage blood sugar in hospitalized adults with diabetes. Forty patients wore a Dexcom G6 device during their hospital stay to track glucose levels. The goal was to see if CGM could reduce dangerous low or…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Baylor Research Institute • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Massive study probes cancer risk of common diabetes drug
Knowledge-focused CompletedThis completed study analyzed health records from over 2 million people with type 2 diabetes to see if those taking dapagliflozin had a different risk of breast or bladder cancer compared to those on other diabetes medications. Researchers tracked cancer diagnoses for up to 12 ye…
Matched conditions: TYPE 2 DIABETES
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:09 UTC
-
Dietary oxysterols linked to diabetes risk in african americans
Knowledge-focused CompletedThis pilot study looked at whether removing oxysterols (harmful compounds in cooked animal foods) from the diet could improve insulin production in African Americans with prediabetes or early type 2 diabetes. Twelve participants ate a plant-based diet free of oxysterols for a per…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Morehouse School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
Could a saliva test spot kidney trouble in diabetics?
Knowledge-focused CompletedThis study measured certain inflammatory markers in the saliva and blood of 126 people with type 2 diabetes, some of whom also had kidney disease (diabetic nephropathy). The goal was to see if these markers differ based on gum health. Researchers hope to better understand the lin…
Matched conditions: TYPE 2 DIABETES
Sponsor: Pamukkale University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
26°C may be the magic number to keep seniors safe in heat waves
Knowledge-focused CompletedThis study looked at whether keeping indoor temperature at 26°C (about 79°F) can prevent dangerous heat strain in older adults during a multi-day heat wave. Researchers exposed 18 adults aged 60-85 to simulated heat conditions over three days and two nights, measuring core temper…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Ottawa • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Stand up for your health: simple swap may lower blood sugar
Knowledge-focused CompletedThis study tested whether replacing sitting with standing or walking during daily life could improve blood sugar levels in South Asian adults who are overweight or obese. Eighteen participants followed two regimens: one with more sitting and one with less sitting. The goal was to…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Bedfordshire • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Nausea drug may unlock new hypertension treatment in diabetes
Knowledge-focused CompletedThis small pilot study looked at whether aprepitant, a drug used for nausea, can reduce aldosterone (a hormone that raises blood pressure) in people with type 2 diabetes and low-renin hypertension. Five participants took either aprepitant or a placebo for two weeks, then switched…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE2 • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Gut check for gums: Surgery's surprising effect on mouth bugs
Knowledge-focused CompletedThis study looked at how bariatric surgery changes the bacteria in the mouths of people with and without type 2 diabetes. Researchers collected blood and plaque samples before and after surgery from 102 participants. The goal was to understand if diabetes alters mouth bacteria in…
Matched conditions: TYPE 2 DIABETES
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Does how you start a glucose monitor matter? new study says maybe
Knowledge-focused CompletedThis study looked at 159 adults with type 2 diabetes to see if the way they are introduced to a continuous glucose monitor (CGM) affects their blood sugar control. One group received a nutrition-focused approach, while the other used a self-directed method. The main goal was to m…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Holly Willis • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Diabetes Drug's cholesterol mystery: new study aims to unravel the why
Knowledge-focused CompletedThis study looks at why dapagliflozin, a diabetes drug, can raise 'bad' cholesterol levels. Researchers will track how the body makes and clears cholesterol in 28 adults with type 2 diabetes over 6 months. Half the participants will get dapagliflozin, the other half a placebo. Th…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Scientists use new imaging to peek inside brown fat in diabetes
Knowledge-focused CompletedThis study looked at how brown adipose tissue (brown fat) works in people with type 2 diabetes. Researchers used special PET scans with a fat-based tracer to measure brown fat activity more accurately than before. The study included 6 participants and aimed to better understand h…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Université de Sherbrooke • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Scientists probe fat metabolism in diabetic Patients' arteries
Knowledge-focused CompletedThis study looked at how diabetes changes the way certain fats (arachidonic acid) are processed in fatty plaques that build up in the carotid artery. Researchers compared plaque samples from 204 diabetic and non-diabetic patients undergoing surgery for carotid stenosis. The goal …
Matched conditions: TYPE 2 DIABETES
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Scientists uncover hormone clues in obesity and diabetes
Knowledge-focused CompletedThis study looked at a recently discovered hormone called 26RFa in 62 women who were obese, some with type 2 diabetes and some without. Researchers measured the hormone levels before and after weight-loss surgery (sleeve gastrectomy) and compared them to healthy-weight volunteers…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University Hospital, Rouen • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Eye game could replace clinic visits for diabetics
Knowledge-focused CompletedThis study tested whether people with diabetes can use a smartphone game to monitor their vision at home, instead of always going to the clinic. 55 participants at high risk for diabetic retinopathy played vision games on their phones for 6 months. The goal was to see if people w…
Matched conditions: TYPE 2 DIABETES
Sponsor: Queen's University, Belfast • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Does your personality affect diabetes foot wounds? new study investigates
Knowledge-focused CompletedThis study explored whether personality type (A or B) and stress levels differ between people with type 2 diabetes who have foot wounds and those who do not. Researchers used questionnaires to measure personality, stress, depression, and quality of life in 66 participants. The go…
Matched conditions: TYPE 2 DIABETES
Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Sitting less, living better: new study targets diabetes in black seniors
Knowledge-focused CompletedThis study worked with Black adults aged 55 and older who have type 2 diabetes to understand why they sit for long periods and how to help them sit less. Researchers used interviews and activity monitors to learn about the social and personal factors that lead to prolonged sittin…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Diabetes diet study: can patients follow the mediterranean way?
Knowledge-focused CompletedThis study looked at how well 60 adults with type 2 diabetes could follow a Mediterranean diet for 12 months. Researchers wanted to see what makes it hard or easy to stick with this healthy eating plan. The goal is to find ways to help more people with diabetes adopt this diet.
Matched conditions: TYPE 2 DIABETES
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Diabetes pill may cut lung cancer risk in COPD patients, study suggests
Knowledge-focused CompletedThis study looked at medical records of over 21,000 adults with type 2 diabetes and COPD to see if a diabetes drug called SGLT2 inhibitor lowers the chance of getting lung cancer compared to an older drug, sulfonylurea. Researchers did not give anyone new medicine; they just anal…
Matched conditions: TYPE 2 DIABETES
Sponsor: Samsung Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Brain clock may play role in diabetes risk
Knowledge-focused CompletedThis completed study looked at whether the brain's central clock (the suprachiasmatic nucleus) works differently in people with insulin resistance or type 2 diabetes. Researchers used advanced MRI scans to measure brain activity over 24 hours in 28 obese adults with varying insul…
Matched conditions: TYPE 2 DIABETES
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Saudi obesity study reveals heart disease links
Knowledge-focused CompletedThis study gathered information from 1,061 adults in Saudi Arabia about their weight, blood sugar, heart health, and lifestyle. The goal was to understand how common heart disease is in people with obesity. Participants filled out a questionnaire during a routine doctor visit, an…
Matched conditions: TYPE 2 DIABETES
Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
New diabetes pill tested in humans for the first time
Knowledge-focused CompletedThis early-stage study tested a new experimental drug, NNC0113-6856, in 70 healthy men to see if it is safe and how the body processes it. Participants received either a single oral dose or an injection into the vein. The goal was to gather initial safety data and measure drug le…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Novo Nordisk A/S • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Healthy volunteers help test new diabetes combo pill
Knowledge-focused CompletedThis study looked at how a new drug combination called CKD-383 is absorbed and processed in the body. It involved 31 healthy adults who took the drug either as a single combined pill or as separate pills. The goal was to compare the two ways of taking the medication, not to treat…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Healthy volunteers test new combo pill for diabetes
Knowledge-focused CompletedThis early-stage study looked at how a new combination diabetes drug, CKD-383, is processed by the body and whether it is safe. Thirty healthy adults took the drug as two tablets together or separately in a random order. The goal was to compare the two ways of taking the medicati…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Healthy volunteers test new diabetes pill combo
Knowledge-focused CompletedThis study looked at how a new combination diabetes drug, CKD-383, moves through the body compared to taking the individual drugs separately. It involved 30 healthy adults who received a single dose of each treatment in a random order. The goal was to measure drug levels and chec…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE1 • Sponsor: Chong Kun Dang Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
AI platform aims to help disabled adults manage chronic diseases
Knowledge-focused CompletedThis study tested a new AI-assisted telehealth program designed to help adults with physical disabilities manage chronic conditions like heart disease, diabetes, and lung disease. Researchers wanted to see if the platform could improve quality of life, physical activity, and medi…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Smartwatch AI could spot diabetes clues without needles
Knowledge-focused CompletedThis completed study tested whether a smartwatch, combined with artificial intelligence, could identify digital signs of type 2 diabetes. Researchers gave 210 adults a multisensor watch to track heart rate and other vitals, then analyzed the data with machine learning. The goal w…
Matched conditions: TYPE 2 DIABETES
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Breathalyzer for diabetes? new study sniffs out blood sugar clues.
Knowledge-focused CompletedThis study looked at whether chemicals in the breath (VOCs) match blood sugar levels in people with type 2 diabetes. Twenty adults with diabetes had their breath and blood sugar measured after drinking sugar water and receiving insulin. The goal was to see if a breath test could …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: DCB Research AG • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Diabetes and mental health: a Two-Year study to personalize care
Knowledge-focused CompletedThis completed study followed 1,290 adults with type 1 or type 2 diabetes for two years. Researchers tracked mental health issues like depression, anxiety, and eating problems alongside daily blood sugar levels using smartphone surveys and continuous glucose monitors. The goal wa…
Matched conditions: TYPE 2 DIABETES
Sponsor: Forschungsinstitut der Diabetes Akademie Mergentheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
One MRI scan to rule them all? new study tests organ health in diabetes
Knowledge-focused CompletedThis study tested whether a single, standardized MRI scan can reliably measure body composition and the health of multiple organs—like the liver, pancreas, heart, and kidneys—in people with type 2 diabetes and healthy volunteers. 43 participants were scanned twice on the same mac…
Matched conditions: TYPE 2 DIABETES
Sponsor: Perspectum • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Prison diabetes classes tested in paris jail
Knowledge-focused CompletedThis study tested whether it is possible to run diabetes education workshops for inmates at Paris' La Santé prison. 22 men with type 1 or type 2 diabetes took part in group classes covering diet, foot care, and medication. The main goal was simply to see if prisoners would attend…
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Tailored workouts may boost heart function in obesity and diabetes
Knowledge-focused CompletedThis study tested whether an 8-week individualized training program could improve heart and blood vessel function in men with obesity or type 2 diabetes. Researchers compared four groups: trained and untrained healthy volunteers, obese subjects, and diabetic patients. The goal wa…
Matched conditions: TYPE 2 DIABETES
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Post-Birth sugar check reveals hidden diabetes risk in moms
Knowledge-focused CompletedThis study looked at 500 women who had gestational diabetes during pregnancy. They took a glucose test 4 to 12 weeks after giving birth to see how many had type 2 diabetes, impaired glucose tolerance, or impaired fasting glucose. The goal was to compare women diagnosed with gesta…
Matched conditions: TYPE 2 DIABETES
Sponsor: Centre Hospitalier Universitaire de Nīmes • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Diabetes drug semaglutide may lower dementia risk, huge study suggests
Knowledge-focused CompletedThis completed study looked at medical records from over 740,000 older adults with diabetes to see if those taking semaglutide had a lower risk of developing dementia compared to those on other diabetes drugs (DPP4 inhibitors). The goal was to find out if semaglutide might help p…
Matched conditions: TYPE 2 DIABETES
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Hidden hypoglycemia: nursing home study tracks dangerous blood sugar dips
Knowledge-focused CompletedThis study looked at how often older adults with diabetes in long-term care facilities experience low blood sugar (hypoglycemia). Researchers used a continuous glucose monitor (CGM) worn for 10 days to track blood sugar levels in 86 participants. The goal was to better understand…
Matched conditions: TYPE 2 DIABETES
Sponsor: Joslin Diabetes Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Massive study pits diabetes drugs against each other for heart protection
Knowledge-focused CompletedThis study looked at real-world medical records from over 887,000 people with type 2 diabetes, overweight, and heart risk to compare two drugs: tirzepatide and semaglutide. The goal was to see which one better prevents serious heart problems like heart attack, stroke, or death. T…
Matched conditions: TYPE 2 DIABETES
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Real-World data mimics heart trial for diabetes drugs
Knowledge-focused CompletedThis completed study tested whether healthcare claims data can predict the results of a major heart trial (SURPASS-CVOT) comparing two diabetes drugs, tirzepatide and dulaglutide. Researchers analyzed records from over 44,000 people with type 2 diabetes and heart disease to see i…
Matched conditions: TYPE 2 DIABETES
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Massive study compares four diabetes drugs for heart safety
Knowledge-focused CompletedThis study looked at health records from over 386,000 adults with type 2 diabetes and moderate heart disease risk. Researchers compared four common second-line diabetes drugs to see which ones were linked to fewer heart attacks, strokes, and other complications. They also asked p…
Matched conditions: TYPE 2 DIABETES
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
Can a tailored diet and exercise program help with insulin resistance? small study tests feasibility
Knowledge-focused CompletedThis study tested whether a personalized lifestyle program could be run in a family medicine clinic for people with insulin resistance and related conditions like obesity, diabetes, and high blood pressure. Forty participants were randomly assigned to start with either nutrition …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Semaglutide's heart benefits explored in new study
Knowledge-focused CompletedThis completed observational study examined whether semaglutide, a drug used for diabetes and weight loss, improves blood flow in the coronary arteries. Researchers measured coronary flow reserve in 122 diabetic and non-diabetic patients before and after 3 months of treatment. Th…
Matched conditions: TYPE 2 DIABETES
Sponsor: Ekrem Bilal Karaayvaz • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
What to eat before exercise? study tests best meal for blood sugar control
Knowledge-focused CompletedThis completed study looked at how different pre-exercise meals affect blood sugar after exercise in 15 men with type 2 diabetes. Participants tried five conditions: fasting, or meals with added sucrose, fructose, fat, or aspartame, each followed by one hour of cycling. The goal …
Matched conditions: TYPE 2 DIABETES
Phase: NA • Sponsor: Paul Poirier • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:00 UTC
-
Diabetes and malaria: a dangerous link in cameroon?
Knowledge-focused CompletedThis completed study in Cameroon followed 406 adults with and without type 2 diabetes for one year. Researchers tested blood and stool samples at four time points to see if diabetes increases the risk of malaria and other parasitic infections. The goal is to understand how non-co…
Matched conditions: TYPE 2 DIABETES
Sponsor: Karolinska Institutet • Aim: Knowledge-focused
Last updated Jun 26, 2026 12:57 UTC